ES2557170T3 - Soporte vascular biodegradable - Google Patents

Soporte vascular biodegradable Download PDF

Info

Publication number
ES2557170T3
ES2557170T3 ES08706826.8T ES08706826T ES2557170T3 ES 2557170 T3 ES2557170 T3 ES 2557170T3 ES 08706826 T ES08706826 T ES 08706826T ES 2557170 T3 ES2557170 T3 ES 2557170T3
Authority
ES
Spain
Prior art keywords
weight
metals
biodegradable
coating
prolaptin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08706826.8T
Other languages
English (en)
Inventor
Erika Hoffmann
Michael Hoffmann
Roland Horres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemoteq AG
Original Assignee
Hemoteq AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200710034350 external-priority patent/DE102007034350A1/de
Application filed by Hemoteq AG filed Critical Hemoteq AG
Application granted granted Critical
Publication of ES2557170T3 publication Critical patent/ES2557170T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A61L31/022—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02—Inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Stent biodegradables a partir de un andamio interior biorreabsorbible que contiene al menos metal, que está rodeado por un recubrimiento biodegradable polimérico y está situado en el microporos de recubrimiento polimérico, agujeros, aberturas, canales u otras estructuras que permitan el paso de iones y recubrimiento luminal se disuelve lentamente como el recubrimiento del stent abluminal.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
5
10
15
20
25
30
35
40
45
50
55
60
65
0,1 en peso.-% -40 en peso.-% Calcio 0,01 en peso.-% -9 en peso.-% Itrio 0,01 en peso.-% -7 en peso.-% Tierras raras 0,01 en peso.-% -4 en peso.-% Otros metales, sales de metales, los no metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
55 en peso.-% -100 en peso.-% Hierro 0,1 en peso.-% -40 en peso.-% Zinc 0,1 en peso.-% -40 en peso.-% Calcio 0,01 en peso.-% -9 en peso.-% Itrio 0,01 en peso.-% -7 en peso.-% Tierras raras 0,01 en peso.-% -4 en peso.-% Otros metales, sales de metales, los no metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
55 en peso.-% -100 en peso.-% Hierro 0,1 en peso.-% -40 en peso.-% Zinc 0,1 en peso.-% -40 en peso.-% Calcio 0,01 en peso.-% -9 en peso.-% Itrio 0,01 en peso.-% -7 en peso.-% Tierras raras 0,01 en peso.-% -4 en peso.-% Otros metales, sales de metales, los no metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
0,1 en peso.-% -30 en peso.-% Hierro 0,1 en peso.-% -30 en peso.-% Zinc 0,1 en peso.-% -30 en peso.-% Calcio 0,1 en peso.-% -30 en peso.-% Magnesio 0,01 en peso.-% -10 en peso.-% Itrio 0,01 en peso.-% -4 en peso.-% Tierras raras 0,01 en peso.-% -4 en peso.-% Otros metales, sales de metales, los no metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
55,0 en peso.-% -75,0 en peso.-% Magnesio 10,0 en peso.-% -20,0 en peso.-% Calcio 5,0 en peso.-% -15,0 en peso.-% Itrio 5,0 en peso.-% -10,0 en peso.-% Otros metales, sales de metales o tierras raras 0,5 en peso.-% -10,0 en peso.-% No metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
20,0 en peso.-% -40,0 en peso.-% Magnesio 20,0 en peso.-% -40,0 en peso.-% Calcio 20,0 en peso.-% -40,0 en peso.-% Zinc 0,0 en peso.-% -5,0 en peso.-% Itrio 0,1 en peso.-% -5,0 en peso.-% Otros metales, sales de metales o tierras raras 0,1 en peso.-% -5,0 en peso.-% No metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
80 en peso.-% -95 en peso.-% Magnesio 0,0 en peso.-% -4 en peso.-% Calcio 0,1 en peso.-% -4 en peso.-% Itrio 0,0 en peso.-% -4 en peso.-% Otros metales, sales de metales o tierras raras 0,1 en peso.-% -4 en peso.-% No metales, carbón, azufre, nitrógeno, oxígeno, hidrógeno.
[0083] En las composiciones enumeradas se entiende que la suma de todos los ingredientes debe totalizar 100.00 en peso .-% de rendimiento. Además, estas composiciones también pueden contener una proporción muy pequeña de impurezas en parte inevitables.
[0084] Como otros metales, entre otras cosas, titanio, circonio, niobio, tantalio, silicio, litio, sodio, potasio y manganeso, y como no metales preferiblemente el carbono, el nitrógeno y el oxígeno.
[0085] El término "absorbible" en la presente invención significa que el implante se disuelve lentamente durante un período de tiempo en el cuerpo y, finalmente, quedan sólo sus productos de degradación en el cuerpo en forma disuelta. En este momento, piezas o fragmentos del implante integrales ya no están disponibles. Los productos de degradación deben ser fisiológicamente inofensivos y en gran medida llevar a iones o moléculas, que están presentes de todos modos, o por el cuerpo degradado o excretado a sustancias inocuas en el organismo.
[0086] Metales adecuados que pueden utilizarse en combinación con el zinc, son preferidamente según la invención, los siguientes: litio, sodio, magnesio, aluminio, potasio, calcio, escandio, titanio, vanadio, cromo, manganeso, hierro,
13
imagen12
imagen13
imagen14
imagen15
5
15
25
35
45
55
65
capa biodegradable y opcional en la capa biodegradable al menos una sustancia farmacológicamente activa. Como sustancias farmacológicamente activas citostáticos, citotóxicos y / o agentes antitrombóticos, antirestenosa, corticoides, hormonas sexuales, estatinas, epotilonas, prostaciclinas, los inductores de la angiogénesis son antiproliferativo, antimigrative, giogene antiangio, antiinflamatorio, antiflogístico, preferido. Entre estas sustancias se prefiere de nuevo el antiproliferativo, antiinflamatorio, antineoplástico, antimigrativem, antiflogístico, citostáticos, citotóxicos y / o agentes antitrombóticos y agentes antirestinosa.
[0118] Los ejemplos de anti-inflamatorios, citostáticos, citotóxicos, antiproliferativa, anti-microtúbulos, ne antiangiogeno, antirestenotico (anti-restenosis), antifúngicos, antineoplásicos, antimigrative, agentes atrombogeneosos y / o anti-trombogénicas incluyen: abciximab, acemetacina, acetilvismio B , aclarrubicina, ademetionina, adriamicina, escina, afromosona, acagerin, aldesleukin, amidoron, aminoglutetemida, amsacrina, anacinra, anastrozol, anemonina, anopterin, antifúngicos, antitrombóticos, apocimarin, argatroban, aristolactam-all, aristolocico, ascomicina, asparaginasa, aspirina, atorvastatina, auranofina, azatioprina, azitromicina, baccatina, bafilomicina, basiliximab, bendamustina, benzocaína, berberina, betulina, ácido betulínico, bilobol, bispartenolidina, bleomicina, bombrestatin, ácidos boswélicos y sus derivados, bruceanola A, B y C, briofilin A, busulfán, antitrombina, bivalirudina, caderinas, camptotecina, capecitabina, ácido o-carbamoilfenoxiacetico, carboplatino, carmustina, celecoxib, cefarantin, cerivastatina, inhibidores de la CETP, cloración de rambucil, la cloroquina, cictoxina, ciprofloxacina, cisplatino, la cladribina, claritromicina, la colchicina, concanamycin, Coumadin, C-péptido natriurético tipo (CNP), cudraisoflavon A, curcumina, ciclofosfamida, ciclosporina A, citarabina, dacarbazina, daclizumab, dactinomicina, dapsona, daunorubicina, diclofenac, 1,11-dimetoxicantin-6-ona, docetaxel, doxorubicina, dunaimyicin, epirubicina, epotilonas A y B, eritromicina, estramustina, etobosid, everolimus, filgrastim, fluroblastin, fluvastatina, fludarabina, fosfato de fludarabina-5'-dihidrógeno, fluorouracilo, folimicin, fosfestrol, gemcitabina, galacinosid, ginkgol, ginkgo, glicósido 1a, 4-hidroxioxiciclofosfamid, idarubicina, ifosfamida, josamicina, lapachol, lomustina, lovastatina, melfalán, midecamicina, mitoxantrona, nimustina, pitavastatina, pravastatina, procar bazin, mitomicina, metotrexato, mercaptopurina, tioguanina, oxaliplatino, irinotecan, topotecan, hidroxicarbamida millones tefosin, pentostatina, pegasparasa, exemestano, letrozol, formestano, SMC proliferación inhibidor-2w, mitoxantrona, micofenolato mofetil, antisentido de c-myc, b-myc antisentido, beta-lapachona, podofilotoxina, zid podofilico-2etilhidra-, molgramostima ( rhuGM-CSF), peginterferón α-2b, lanograstim (r-Hug-CSF), macrogol, selectina (Cytokinantago-NIST), inhibidores de citocinas, la COX-2 inhibidor, NFkB, angiopeptina, anticuerpos monoclonales que inhiben la proliferación de células musculares, bFGF antagonistas, probucol, prostaglandinas, 1-hidroxi-11metoxicantin-6-ona, scopolectin, NO donoren como pentaeritritiltetranitrat y sindnoeimine, nitrosados-S, tamoxifen, estaurosporina, ß-estradiol, α-estradiol, estriol, estrona, etinil estradiol, medroxiprogesterona, estradiolcipionato, estradiolbenzoato, tranilast, camebacaurin y otros terpenoides, que se utilizan en el tratamiento de cáncer, verapamil, inhibidores de tirosina quinasa (tirfostina), paclitaxel y sus derivados tales como 6-α-hidroxi-paclitaxel, taxotere, subóxido de carbono (MCS) y los oligómeros macrocíclicos mofebutazona, lonazolaco, lidocaína, cetoprofeno, mefenámico, piroxicam, meloxicam, penicilamina, hidroxicloroquina, aurotiomalato sodio, oxaceprol, βsitosterol, mirtecain, polidocanol, nonivamida, levomentol, elipticina, D -24 851 (calbiochem), colcemid citocalasina AE, indanocina, nocadazole, proteína S 100, bacitracina, antagonistas del receptor de vitronectina, azelastina, guanidilciclasa estimulador de la incorporación de tejido inhibidor de metalproteinasa-1 y 2, ácidos nucleicos libres, ácidos nucleicos en vectores virales, DNA -y fragmentos de ARN, Plaminogeno activador inhibidor-1, inhibidor del activador del plasminógeno-2, oligonucleótidos antisentido, inhibidores VEGF, IGF-1, los ingredientes activos del grupo de antibióticos tales como cefadroxil, cefazolina, cefaclor, Cefotixin tobramicina, gentamicina, penicilina como dicloxacilina, oxacilina, sulfonamidas, metronidazol, enoxoparina, desulfatada y heparina N-reacetilado, activador del plasminógeno tisular, receptor de membrana de las plaquetas GPIIb / IIIa, el anticuerpo inhibidor del factor Xa, heparina, hirudina, r-hirudina, PPACK, protamina, prouroquinasa, estreptoquinasa, warfarina, uroquinasa, vasodilatadores como el dipiridamol, trapidil, nitroprusiato, antagonistas de PDGF como triazolopirimidina y Seramin, los inhibidores de la ECA como captopril, cilazapril, lisinopril, enalapril, losartan, tioproteaseinhibitoren, prostaciclina, Vapiprost, interferón α ,ßy γ, antagonistas de la histamina, bloqueadores de serotonina, inhibidores de la apoptosis, reguladores de la apoptosis tales como p65, NF-kB o oligonucleótidos antisentido Bcl-XL, halofuginona, nifedipina, tranilast tocoferol, molsidomina, los polifenoles del té, galato de epicatequina, galato de epigalocatequina, leflunomida, etanercept, sulfasalazina, etopósido, dicloxacylina, tetraciclina, triamcinolona, mutamicina, Procainimid, nolsäure retina, quinidina, disopyrimida, flecainida, propafenona, sotolol, natural y esteroide producida sintéticamente como Inotodiol, maquirosid A, ghalakinosid, mansonina, streblosida, hidrocortisona, betametasona, dexametasona, roidale nichtste-sustancias (AINES), como el fenoprofeno, ibuprofeno, indometacina, naproxeno, fenilbutazona y otros agentes antivirales como el aciclovir, ganciclovir y zidovudina, clotrimazol, flucitosina, griseofulvina, ketoconazol, miconazol, nistatina, terbinafina, agentes antiprozoale como la cloroquina, mefloquina, quinina, otros terpenoides naturales como pocaesculin cadera, barringtogenol-C21-angelat, 14-dehidroagrostistachin, agrosquerin, agrostistachin, 17-hidroxiagrostistachina, ovatodiolida, 4,7-oxycycloanisomelico, baccharinoide B1, B2, B3 y B7, tubeimosida, bruceantinosida C, yadanziosida N, y P, isodeoxielefantopina, tomenfantopina A y B, coronarin A, B, C y D, ácido ursólico, ácido hiptatico A, iso-iridogermanal. Maitenfoliol, efusantin A, excisanin A y B, longicaurina B, C sculponeatin, fasudilo, camebaunin, leucamenina A y B, 13,18-dehidro-6-alfa-senecioyloxichaparrin, taxamairin A y B, regenilol, triptólido, cimarina, hidroxianopterina, protoanemonina, cheliburinchlorida, sinococulina A y B, dihidronitidina, cloruro de nitidina, 12-beta-3,20-diona hidroxipregnadien, helenalina, indicin, indicin-N-óxido, lasiocarpin, inotodiol, podofilotoxina, justicidina A y B, larreatin, malloterin , malotochromanol, isobutirilmallotochromanol, maquirosid A, marchantin A, maitansina, lycoridicin, margetin, pancratistatina, liriodenina, bispsrthenolidina, oxoushinsunin, periplocosida A, ácido ursólico, deoxypsorospermina, psycorubina, ricina A,
18
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21

Claims (1)

  1. imagen1
    imagen2
    imagen3
ES08706826.8T 2007-01-30 2008-01-30 Soporte vascular biodegradable Active ES2557170T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102007005474 2007-01-30
DE102007005474 2007-01-30
DE102007034350 2007-07-24
DE200710034350 DE102007034350A1 (de) 2007-07-24 2007-07-24 Biologisch abbaubare Gefäßstütze
PCT/DE2008/000160 WO2008092435A2 (de) 2007-01-30 2008-01-30 Biologisch abbaubare gefässstütze

Publications (1)

Publication Number Publication Date
ES2557170T3 true ES2557170T3 (es) 2016-01-22

Family

ID=39674532

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08706826.8T Active ES2557170T3 (es) 2007-01-30 2008-01-30 Soporte vascular biodegradable

Country Status (13)

Country Link
US (1) US20100076544A1 (es)
EP (1) EP2114481B1 (es)
JP (1) JP5391082B2 (es)
KR (1) KR20090122202A (es)
AU (1) AU2008210149B2 (es)
BR (1) BRPI0807830B8 (es)
CA (1) CA2673914C (es)
ES (1) ES2557170T3 (es)
IL (1) IL199569A (es)
MX (1) MX2009008064A (es)
PL (1) PL2114481T3 (es)
RU (1) RU2452517C2 (es)
WO (1) WO2008092435A2 (es)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002345328A1 (en) 2001-06-27 2003-03-03 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
CA2659761A1 (en) 2006-08-02 2008-02-07 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
JP2010503491A (ja) * 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド 生物学的安定性無機層を有する生浸食性エンドプロスシーシス
WO2008034031A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
US8052744B2 (en) 2006-09-15 2011-11-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
ATE517590T1 (de) 2006-09-15 2011-08-15 Boston Scient Ltd Biologisch erodierbare endoprothesen
WO2008036548A2 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
ATE488259T1 (de) 2006-12-28 2010-12-15 Boston Scient Ltd Bioerodierbare endoprothesen und herstellungsverfahren dafür
DE102007038799A1 (de) * 2007-08-17 2009-02-19 Biotronik Vi Patent Ag Implantat aus einer biokorrodierbaren Magnesiumlegierung und mit einer Beschichtung aus einem biokorrodierbaren Polyphosphazen
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US9855370B2 (en) 2008-01-08 2018-01-02 Yale University Compositions and methods for promoting patency of vascular grafts
WO2009102787A2 (en) * 2008-02-12 2009-08-20 Boston Scientific Scimed, Inc. Medical implants with polysaccharide drug eluting coatings
WO2009113605A1 (ja) * 2008-03-12 2009-09-17 アンジェスＭｇ株式会社 薬剤溶出型カテーテル及びその製造方法
DE102008020415A1 (de) * 2008-04-24 2009-10-29 Biotronik Vi Patent Ag Biodegradierbare metallische Stents mit Wachsschicht
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US9119906B2 (en) 2008-09-24 2015-09-01 Integran Technologies, Inc. In-vivo biodegradable medical implant
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
DE102008043277A1 (de) * 2008-10-29 2010-05-06 Biotronik Vi Patent Ag Implantat aus einer biokorrodierbaren Eisen- oder Magnesiumlegierung
US8735354B2 (en) * 2008-11-07 2014-05-27 Uab Research Foundation Endothelium mimicking nanomatrix
US9283304B2 (en) * 2008-11-25 2016-03-15 CARDINAL HEALTH SWITZERLAND 515 GmbH Absorbable stent having a coating for controlling degradation of the stent and maintaining pH neutrality
WO2010101901A2 (en) 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8435281B2 (en) 2009-04-10 2013-05-07 Boston Scientific Scimed, Inc. Bioerodible, implantable medical devices incorporating supersaturated magnesium alloys
US8137396B2 (en) * 2009-05-20 2012-03-20 480 Biomedical, Inc Medical implant
US20110319987A1 (en) * 2009-05-20 2011-12-29 Arsenal Medical Medical implant
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
US8888840B2 (en) * 2009-05-20 2014-11-18 Boston Scientific Scimed, Inc. Drug eluting medical implant
US8252022B2 (en) * 2009-07-13 2012-08-28 Vascular Solutions, Inc. Metal vascular aperture closure device
US20130131814A1 (en) * 2009-12-07 2013-05-23 Ja-Kyo Koo Implant
EP2338536B1 (de) * 2009-12-21 2015-08-05 Biotronik VI Patent AG Biokorrodierbare Implantate mit funktionalisierter Beschichtung
WO2011119573A1 (en) 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US10292808B2 (en) 2010-06-07 2019-05-21 Q3 Medical Devices Limited Device and method for management of aneurism, perforation and other vascular abnormalities
EP2399620B1 (de) 2010-06-28 2016-08-10 Biotronik AG Implantat und Verfahren zur Herstellung desselben
CN102371006B (zh) * 2010-08-17 2014-08-20 上海微创医疗器械（集团）有限公司 一种生物可降解支架
EP2624834A4 (en) * 2010-10-04 2014-09-17 Elixir Medical Corp MACROCYCLIC LACTON COMPOUNDS AND METHOD FOR THEIR USE
US20120150282A1 (en) * 2010-12-10 2012-06-14 Biotronik Ag Implant having a paclitaxel-releasing coating
TWI548427B (zh) 2010-12-21 2016-09-11 星瑟斯有限公司 含有生物可降解鎂系合金之醫療植入物及其製造方法
US9522219B2 (en) * 2011-08-15 2016-12-20 Hemoteq Ag Resorbable stents which contain a magnesium alloy
CA2858275A1 (en) * 2012-01-23 2013-08-01 Cortronik GmbH Device for coating a stent and associated coating method and stent produced according to the method
EP2630978B1 (de) * 2012-02-22 2018-10-31 Biotronik AG Implantat und verfahren zur herstellung desselben
WO2013133847A1 (en) * 2012-03-09 2013-09-12 Eventions, Llc Biodegradable supporting device
US8834902B2 (en) 2012-03-09 2014-09-16 Q3 Medical Devices Limited Biodegradable supporting device
US9333099B2 (en) * 2012-03-30 2016-05-10 Abbott Cardiovascular Systems Inc. Magnesium alloy implants with controlled degradation
RU2519103C2 (ru) * 2012-08-13 2014-06-10 Федеральное государственное бюджетное учреждение "Научный центр сердечно-сосудистой хирургии имени А.Н. Бакулева" Российской академии медицинских наук Биорезорбируемая гидрогелевая полимерная композиция с биологически активными веществами (варианты)
US9700441B2 (en) * 2012-10-31 2017-07-11 W. L. Gore & Associates, Inc. Devices and methods related to deposited support structures
US10959715B2 (en) 2012-10-31 2021-03-30 W. L. Gore & Associates, Inc. Devices and methods related to deposited support structures
US11744594B2 (en) 2012-11-16 2023-09-05 W.L. Gore & Associates, Inc. Space filling devices
KR101461162B1 (ko) * 2013-01-29 2014-11-13 서울대학교산학협력단 접착성 물질을 이용하여 신체 이식 후 이동을 최소화하는 스텐트 및 방법
EP2767295B1 (de) 2013-02-13 2015-11-04 Biotronik AG Biokorrodierbares Implantat mit korrosionshemmender Beschichtung
EP2767294B1 (de) 2013-02-13 2018-03-21 Biotronik AG Biokorrodierbares Implantat mit korrosionshemmender Beschichtung
KR101722036B1 (ko) * 2013-12-26 2017-03-31 주식회사 삼양바이오팜 약물 방출 조절형 생분해성 스텐트용 약물 코팅제 및 그 제조방법, 및 이 코팅제로 코팅된 생분해성 스텐트 및 그 제조방법
CN103736152B (zh) * 2013-12-26 2016-12-07 西安爱德万思医疗科技有限公司 一种人体可吸收的耐蚀高强韧锌合金植入材料
JP2015180247A (ja) * 2014-03-03 2015-10-15 国立大学法人 岡山大学 薬剤放出層を有するインプラント
WO2015147183A1 (ja) * 2014-03-28 2015-10-01 古河電気工業株式会社 亜鉛合金管材とその製造方法、及びそれを用いてなるステントとその製造方法
RU2728703C2 (ru) * 2014-05-02 2020-07-31 Рисерч Инститьют Эт Нэшнуайд Чилдрен`С Хоспитал Композиции и способы для анти-lyst иммуномодуляции
WO2015171911A1 (en) * 2014-05-09 2015-11-12 Mayo Foundation For Medical Education And Research Devices and methods for forming stents in vivo
RU2551938C1 (ru) * 2014-07-14 2015-06-10 Общество с ограниченной ответственностью "Инновационная компания "Современные технологии" Многоцелевой сосудистый имплант
CN105797220B (zh) * 2014-12-31 2020-07-31 先健科技(深圳)有限公司 可降解铁基合金支架
JP6715254B2 (ja) 2015-02-20 2020-07-01 スリーエム イノベイティブ プロパティズ カンパニー 感圧接着剤含有物品用剥離層としてのシリコーンカーボネートポリマー
KR20160122948A (ko) * 2015-04-14 2016-10-25 주식회사 바이오알파 생체 내 생분해 속도가 조절된 생분해성 스텐트 및 이의 제조 방법
WO2017100782A1 (en) 2015-12-11 2017-06-15 Research Institute At Nationwide Children's Hospital Systems and methods for optimized patent specific tissue engineering vascular grafts
CN106902395B (zh) 2015-12-22 2020-04-07 先健科技(深圳)有限公司 可吸收铁基合金植入医疗器械
CN106955374B (zh) * 2016-01-08 2019-11-08 先健科技(深圳)有限公司 植入式器械
WO2017204803A1 (en) * 2016-05-25 2017-11-30 Q3 Medical Devices Limited Biodegradable supporting device
CZ309165B6 (cs) * 2016-10-20 2022-04-06 Ústav Struktury A Mechaniky Hornin Av Čr, V. V. I. Příprava nanokompozitní vrstvy na bázi kolagenových nanovláken
JP2018196401A (ja) * 2017-05-19 2018-12-13 ロレアル マイクロニードルシート
SE545102C2 (en) 2018-04-25 2023-04-04 Bactiguard Ab A surface coating for use in the prophylaxis of allergy
KR102302544B1 (ko) * 2019-03-26 2021-09-15 형태경 스텐트 제조용 생분해성 수지 조성물
CN114051417A (zh) 2019-07-09 2022-02-15 大塚医疗器械有限公司 药剂溶出型支架
RU2725644C1 (ru) * 2019-12-11 2020-07-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет пищевых производств" Биодеградируемая полимерная композиция с антимикробными свойствами на основе полиолефинов
RU2733708C1 (ru) * 2020-01-31 2020-10-06 Общество с ограниченной ответственностью «ЦЕНТР НОВЫХ МАТЕРИАЛОВ» Способ получения композиционного биомедицинского материала «никелид титана-полилактид» с возможностью контролируемой доставки лекарственных средств
CN111494794B (zh) * 2020-05-08 2021-12-28 山东百多安医疗器械股份有限公司 一种具有调节血管功能的锌合金支架系统
RU2741986C1 (ru) * 2020-05-12 2021-02-01 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кабардино-Балкарский государственный университет им. Х.М. Бербекова" (КБГУ) Биоразлагаемый материал
DE202021100450U1 (de) * 2021-01-29 2021-02-18 Biotronik Ag Schnell resorbierbares intravaskuläres Implantat
DE102021103786B4 (de) * 2021-02-17 2023-07-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Implantat zum Implantieren in einen Organismus und Verfahren
CN113142015B (zh) * 2021-04-22 2022-03-04 西南科技大学 一种天然砂石浆洗淤泥制备有机营养土的方法
US11998192B2 (en) 2021-05-10 2024-06-04 Cilag Gmbh International Adaptive control of surgical stapling instrument based on staple cartridge type
CN114522253B (zh) * 2021-12-24 2023-05-26 重庆医科大学附属第二医院 多功能纳米粒及其制备方法、应用
CN115337463B (zh) * 2022-04-18 2023-10-13 东南大学 一种双载药微球-静电纺丝覆膜支架的制备方法及应用
KR102819136B1 (ko) * 2022-06-30 2025-06-11 인제대학교 산학협력단 신주락톤 a를 포함하는 혈관 염증 치료용 조성물
US20250049595A1 (en) * 2023-08-11 2025-02-13 Dev GADHIA Zotarolimus-rosuvastatin eluting biodegradable stent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8172897B2 (en) * 1997-04-15 2012-05-08 Advanced Cardiovascular Systems, Inc. Polymer and metal composite implantable medical devices
US6240616B1 (en) * 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US10028851B2 (en) * 1997-04-15 2018-07-24 Advanced Cardiovascular Systems, Inc. Coatings for controlling erosion of a substrate of an implantable medical device
US20060271168A1 (en) * 2002-10-30 2006-11-30 Klaus Kleine Degradable medical device
DE10253634A1 (de) 2002-11-13 2004-05-27 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Endoprothese
US7758892B1 (en) * 2004-05-20 2010-07-20 Boston Scientific Scimed, Inc. Medical devices having multiple layers
JP5026970B2 (ja) * 2004-05-20 2012-09-19 ボストン サイエンティフィック リミテッド 医療デバイスおよびそれを作製する方法
CA2885981A1 (en) * 2005-04-05 2006-10-12 Elixir Medical Corporation Degradable implantable medical devices
DE102005018356B4 (de) * 2005-04-20 2010-02-25 Eurocor Gmbh Resorbierbare Implantate
KR20080008364A (ko) * 2005-05-05 2008-01-23 헤모텍 아게 관 스텐트의 전면 코팅
DE102006038235A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Verbesserung der Stabilität biodegradierbarer metallischer Stents, Verfahren und Verwendung
DE102006038236A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Biodegradierbarer Stent mit einer aktiven Beschichtung
DE102006038241A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Stent mit einer genisteinhaltigen Beschichtung oder Kavitätenfüllung
US7651527B2 (en) * 2006-12-15 2010-01-26 Medtronic Vascular, Inc. Bioresorbable stent

Also Published As

Publication number Publication date
CA2673914C (en) 2013-10-08
CA2673914A1 (en) 2008-08-07
EP2114481B1 (de) 2015-09-30
BRPI0807830A2 (pt) 2011-09-13
WO2008092435A2 (de) 2008-08-07
RU2009132530A (ru) 2011-03-10
KR20090122202A (ko) 2009-11-26
WO2008092435A3 (de) 2009-07-30
AU2008210149A1 (en) 2008-08-07
BRPI0807830B1 (pt) 2018-07-17
AU2008210149B2 (en) 2011-07-14
WO2008092435A9 (de) 2009-10-15
US20100076544A1 (en) 2010-03-25
MX2009008064A (es) 2009-08-07
PL2114481T3 (pl) 2016-03-31
IL199569A (en) 2014-02-27
RU2452517C2 (ru) 2012-06-10
BRPI0807830B8 (pt) 2021-06-22
JP5391082B2 (ja) 2014-01-15
EP2114481A2 (de) 2009-11-11
JP2010516414A (ja) 2010-05-20

Similar Documents

Publication Publication Date Title
US20110076319A1 (en) Bioresorbable metal stent with controlled resorption
US20100076542A1 (en) Coated expandable system
CN102458497B (zh) 涂有虫胶和太平洋紫杉醇的导管球囊
US8679520B2 (en) Coating of stents for preventing restenosis
RU2009132530A (ru) Биоразрушаемое средство для поддерживания просвета сосудов
CA2540382A1 (en) Biocompatible, biostable coating of medical surfaces
CN101636187B (zh) 生物可降解性血管支持器
EP2125060B1 (de) Verfahren zur beladung von strukturierten oberflächen
DE102005021622B4 (de) Ganzflächige Beschichtung von Stents
EP1913962A1 (en) Expandable medical device for the treatment and prevention of cardiovascular diseases
JP2005506146A5 (es)
RU2012157314A (ru) Нанесения на эндопротез покрытия, состоящего из плотной сети полимерных волокон
CA2558141A1 (en) Biocompatible coating, method and use of medical surfaces
DE102005018356A1 (de) Resorbierbare Implantate
EP2233162A2 (de) Medizinisches Implantat zur Medikamentenfreisetzung mit poröser Oberfläche
DE202012009561U1 (de) 3D Hergestellte bioresorbierbaren Nano Stents und deren Verwendung
DE102005039126A1 (de) Parylene-beschichtete expandierbare Vorrichtung
DE102004046244A1 (de) Beschichtetes Coronarstentsystem
DE202013002567U1 (de) NABP - Beschichtung
DE202012006700U1 (de) Beschichtung
EP2213316A1 (de) Iod-Beschichtete expandierbare Vorrichtung
DE102007010354A1 (de) Beschichtete expandierbare Vorrichtung
DE202011002929U1 (de) Stent zur Implantation in den menschlichen Körper
WO2012028310A2 (en) Pharmaceutical compositions comprising a taxane
IL174492A (en) Biocompatible, biostable coating of medical surfaces